Athena Drug Delivery Solutions Private Limited Mesalamine Export Data — India (DGFT 2022–2026)

Name: Athena Drug Delivery Solutions Private Limited Mesalamine Export Records India — #7 Exporter, 15 Shipments, $750.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Mesalamine

India Pharmaceutical Trade Intelligence

$1.3B103 Suppliers51 CountriesHS 30049099

ExportsIndia → UNITED STATES98.6%India → RUSSIA0.4%

ImportsUNITED STATES → India$1.0M ISRAEL → India$27.3K

#1 Supplier: ZYDUS LIFESCIENCES #1 Buyer: EVERSANA LIFE

Athena Drug Delivery Solutions Private Limited — Mesalamine Exporter #7 | $750.0K Trade Value | TransData Nexus | TransData Nexus

Athena Drug Delivery Solutions Private Limited — Mesalamine Exporter Profile

Indian Pharmaceutical Exporter · #7 for Mesalamine · $750.0K export value · DGFT Verified

Athena Drug Delivery Solutions Private Limited is the #7 Indian exporter of Mesalamine with $750.0K in export value and 15 verified shipments. Athena Drug Delivery Solutions Private Limited holds a 0.1% market share in Mesalamine exports across 1 countries. The company exports 6 pharmaceutical products worth $10.0M across 4 therapeutic categories.

Athena Drug Delivery Solutions Private Limited — Mesalamine Export Profile: Buyers & Destinations

Athena Drug Delivery Solutions Private Limited Mesalamine export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Mesalamine?

Country	Value	Shipments	Share
UNITED STATES	$43.8M	875	85.8%
RUSSIA	$1.9M	38	3.7%
MEXICO	$950.0K	19	1.9%
BRAZIL	$850.0K	17	1.7%

Who Are the Top Buyers of Mesalamine from India?

Buyer	Country	Value	Orders
EVERSANA LIFE SCIENCE SERVICES	UNITED STATES	$15.8M	317
NORTHSTAR DISTRIBUTION CENTER 8912	UNITED STATES	$3.1M	63
SUN PHARMACEUTICAL INDUSTRIES,INC.	UNITED STATES	$2.1M	42
SUN PHARMACEUTICAL INDUSTRIES INC	UNITED STATES	$1.9M	37
AO RANBAXY	RUSSIA	$1.2M	24
SUN PHARMACEUTICAL INDUSTRIES, INC.	UNITED STATES	$750.0K	15
AO "RANBAXY"	RUSSIA	$600.0K	12
EVERSANA LIFE SCIENCE SERVICES,	UNITED STATES	$200.0K	4
XXN PXXRMAXXUTIXXL IXXUSTXXES XXC	UNITED STATES	$150.0K	3
NORTHSTAR DISTRIBUTION CENTER	UNITED STATES	$150.0K	3

India's Mesalamine is purchased by 214 buyers worldwide. The top buyer is EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), followed by NORTHSTAR DISTRIBUTION CENTER 8912 and SUN PHARMACEUTICAL INDUSTRIES,INC..

How Does Athena Drug Delivery Solutions Private Limited Compare to Nearest Mesalamine Exporters?

Exporters ranked immediately above and below #7 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
11	ALEMBIC PHARMACEUTICALS LIMITED	$1.1M	38	1	$29.9K
6	SUN PHARMACEUTICAL INDUSTRIES LTD	$750.0K	15	2	$50.0K
7	ATHENA DRUG DELIVERY SOLUTIONS PRIVATE LIMITED ★	$750.0K	15	1	$50.0K
5	CADILA HEALTHCARE LTD	$450.0K	9	1	$50.0K
10	MYLAN LABORATORIES LIMITED	$450.0K	9	2	$50.0K

Athena Drug Delivery Solutions Private Limited ranks #7 among 103 Indian Mesalamine exporters. Average shipment value of $50.0K compared to the market average of $469.7K. The closest competitors by value are ALEMBIC PHARMACEUTICALS LIMITED and SUN PHARMACEUTICAL INDUSTRIES LTD.

Which Indian Ports Ship Mesalamine Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	801	21.2%
SAHAR AIR	789	20.9%
DELHI AIR	494	13.1%
SAHAR AIR CARGO ACC (INBOM4)	415	11.0%
MUNDRA SEA	134	3.5%
Delhi Air	131	3.5%
Bombay Air	120	3.2%
NHAVA SHEVA SEA (INNSA1)	70	1.9%

Geopolitical & Trade Policy Impact on Athena Drug Delivery Solutions Private Limited's Mesalamine Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Athena. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing significant delays and increased freight costs. These maritime disruptions have the potential to impact up to $600 million in Indian pharmaceutical exports to the West Asia and North Africa (WANA) region, a critical market for generic drug manufacturers. (pharmaceuticalcommerce.com)

Conversely, escalating US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the US market. However, the imposition of tariffs on pharmaceutical imports by the US poses a threat to this opportunity. In August 2025, the US administration imposed broad tariffs on imports from over 60 countries, including India, with rates reaching as high as 39%. These tariffs could significantly impact Indian exporters, as nearly 55% of the country's outbound shipments to America are affected. (apnews.com)

In the European Union, regulatory changes such as the Falsified Medicines Directive (FMD) have introduced stringent compliance requirements. Indian exporters must adapt to these evolving standards to maintain market access. The India–EFTA Trade and Economic Partnership Agreement, effective from October 2025, aims to eliminate or reduce tariffs on goods traded between India and EFTA countries, potentially benefiting companies like Athena. (en.wikipedia.org)

Athena Drug Delivery Solutions Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The US FDA has intensified inspections, conducting over 200 in 2023, with plans to increase this number in 2024. This heightened scrutiny underscores the necessity for companies like Athena to invest in robust quality control systems and ensure adherence to Good Manufacturing Practices (GMP). (fact.net.in)

Instances of counterfeit drugs have also raised concerns about the reputation of Indian pharmaceutical exports. Approximately 35% of the world's counterfeit drugs are estimated to originate from India, highlighting the critical need for stringent quality assurance measures. (fact.net.in)

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Mesalamine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Athena Drug Delivery Solutions Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 51+ countries, 214+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Mesalamine

Mesalamine

Athena Drug Delivery Solutions Private Limited — Mesalamine Exporter Profile

Athena Drug Delivery Solutions Private Limited — Mesalamine Export Profile: Buyers & Destinations

Where Does India Export Mesalamine?

Who Are the Top Buyers of Mesalamine from India?

What Is India's Total Mesalamine Export Value and How Much Does Athena Drug Delivery Solutions Private Limited Contribute?

What Is the Average Shipment Value for Athena Drug Delivery Solutions Private Limited's Mesalamine Exports?

How Does Athena Drug Delivery Solutions Private Limited Compare to Other Indian Mesalamine Exporters?

Regulatory Requirements: Exporting Mesalamine to Key Markets

United States — FDA

Mexico — COFEPRIS

How Does Athena Drug Delivery Solutions Private Limited Compare to Nearest Mesalamine Exporters?

Which Indian Ports Ship Mesalamine Exports?

What Other Gastrointestinal Products Does Athena Drug Delivery Solutions Private Limited Export?

Geopolitical & Trade Policy Impact on Athena Drug Delivery Solutions Private Limited's Mesalamine Exports

Athena Drug Delivery Solutions Private Limited — Regulatory Compliance & Quality Standards

About Athena Drug Delivery Solutions Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Mesalamine Export Data from Athena Drug Delivery Solutions Private Limited

Mesalamine Stats

Company Overview

Top Products by Athena Drug Delivery Solutions Private Limited

Related Analysis

Need Detailed Export Data?

Data Source